Aurora Burlington Price of In Situ Hybridization, Semi-Quantitative Manual is $695

Overview: In Situ Hybridization, Semi-Quantitative Manual is a specialized laboratory procedure offered at Aurora Medical Center Burlington for $695. This technique is primarily used to detect and visualize specific DNA or RNA sequences within tissue samples, playing a critical role in diagnosing various diseases, especially cancers. The semi-quantitative manual approach yields detailed, approximate measurements of nucleic acid expression, which supports precise diagnosis and personalized treatment planning. The listed fee generally covers the laboratory analysis, specialized reagents, and technical expertise required for the manual process; however, it may not include related physician interpretation or additional pathology fees. To avoid unexpected charges, patients are encouraged to request a detailed, itemized cost estimate and clarify what is included in the procedure fee prior to service.

Cost Breakdown

• Procedure Fee ($695): Covers tissue sample preparation, application of specialized probes, and manual analysis.
• Lab Materials: Includes reagents and slides used for hybridization.
• Technical Labor: Reflects the expertise of laboratory personnel conducting and interpreting the procedure.
• Potential Additional Fees: May include pathologist review, consultation, or follow-up diagnostic tests.

Associated Costs

• Biopsy or Tissue Collection: The cost of obtaining the tissue sample is typically billed separately.
• Pathologist Interpretation: Professional reading and reporting may incur additional charges.
• Follow-Up Testing: Further analyses, if needed, may not be included in the initial fee.

Insurance & Payment Advice

• Verify with your insurance provider whether this procedure is covered under your plan, especially for your specific diagnosis.
• Request pre-authorization if required by your insurer to avoid denial of claims.
• Ask for a written, itemized estimate from the provider, including all associated services.
• Inquire about payment plans or financial assistance if you are uninsured or underinsured.

Frequently Asked Questions

• What is In Situ Hybridization, Semi-Quantitative Manual?
  It is a laboratory procedure that detects and visualizes specific nucleic acid (DNA/RNA) sequences within tissue samples, providing approximate measurements of their expression levels.
• What does the $695 fee include?
  The fee generally covers the laboratory processing, specialized reagents, and technical analysis, but may not include tissue collection or pathologist interpretation.
• Why might I need this procedure?
  This test is often used in cancer diagnostics to identify genetic markers, helping guide accurate diagnosis and treatment planning.
• Are there additional costs beyond the listed fee?
  Yes, there may be separate charges for tissue collection (biopsy), physician interpretation, or follow-up testing.
• Will insurance cover this procedure?
  Coverage varies by insurance plan and diagnosis; check with your insurer and obtain pre-authorization if needed.
• How does “semi-quantitative” differ from other methods?
  It provides an approximate (not absolute) measurement of nucleic acid levels, offering more detail than qualitative tests but less precision than fully quantitative methods.
• How should I prepare for the procedure?
  Preparation instructions depend on the tissue source; your healthcare provider will give specific guidance if a biopsy is required.
• How long does it take to receive results?
  Turnaround time varies, but results are typically available within several days to a week after the sample reaches the laboratory.
• Can this test be used for conditions other than cancer?
  Yes, it is used in diagnosing a range of diseases that require detection of specific DNA or RNA sequences in tissues.
• Are there risks or side effects to this test?
  The laboratory analysis itself is safe; risks may be associated with the tissue biopsy, such as bleeding or infection.
• What should I do if I have concerns about cost?
  Discuss your concerns with the billing office; request an itemized estimate and inquire about financial aid or payment options.

Aurora Medical Center Burlington offers a specialized medical service known as In Situ Hybridization, Semi-Quantitative Manual, which is priced at $695. This procedure is a laboratory technique used to detect specific nucleic acid sequences within tissue sections. It is often employed in the diagnosis and research of various diseases, including cancer, by allowing pathologists to visualize the presence and location of specific DNA or RNA sequences. The semi-quantitative manual approach provides detailed insights into the expression levels of these sequences, aiding in accurate diagnosis and treatment planning.

What is In Situ Hybridization? – In Situ Hybridization is a laboratory technique used to detect specific nucleic acid sequences within tissue samples, often used in disease diagnosis and research.

Why is it called "semi-quantitative"? – The term "semi-quantitative" refers to the method’s ability to provide approximate measurements of nucleic acid levels, offering more detail than qualitative methods but not as precise as fully quantitative techniques.

How does this procedure aid in cancer diagnosis? – This procedure helps identify specific genetic markers associated with cancer, allowing for more accurate diagnosis and personalized treatment plans.

Is this service available for all types of diseases? – While commonly used in cancer diagnostics, In Situ Hybridization can be applied to various diseases where genetic information is crucial for diagnosis.

What makes the manual approach different? – The manual approach involves hands-on techniques by skilled technicians, which can offer more tailored results compared to automated methods.

How long does the procedure take? – The duration of the procedure can vary depending on the complexity of the sample and the specific sequences being analyzed.

Is the cost of $695 covered by insurance? – Coverage for this procedure depends on individual insurance plans and the specific medical necessity as determined by healthcare providers.

What should patients expect during the procedure? – Patients typically do not experience the procedure directly, as it involves laboratory analysis of tissue samples collected during prior medical procedures.